JP2015505842A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015505842A5 JP2015505842A5 JP2014546193A JP2014546193A JP2015505842A5 JP 2015505842 A5 JP2015505842 A5 JP 2015505842A5 JP 2014546193 A JP2014546193 A JP 2014546193A JP 2014546193 A JP2014546193 A JP 2014546193A JP 2015505842 A5 JP2015505842 A5 JP 2015505842A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- pharmaceutically acceptable
- racemate
- enantiomer
- solvate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(C)(CC*CC(*)C*CC1)CC1C(NI)=O Chemical compound CC(C)(CC*CC(*)C*CC1)CC1C(NI)=O 0.000 description 5
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161569754P | 2011-12-12 | 2011-12-12 | |
| US61/569,754 | 2011-12-12 | ||
| US201161570789P | 2011-12-14 | 2011-12-14 | |
| US61/570,789 | 2011-12-14 | ||
| US201261734300P | 2012-12-06 | 2012-12-06 | |
| US61/734,300 | 2012-12-06 | ||
| PCT/US2012/069289 WO2013090454A2 (en) | 2011-12-12 | 2012-12-12 | Novel glp-1 receptor modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015505842A JP2015505842A (ja) | 2015-02-26 |
| JP2015505842A5 true JP2015505842A5 (enExample) | 2016-02-04 |
| JP6061949B2 JP6061949B2 (ja) | 2017-01-18 |
Family
ID=47436261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014546193A Expired - Fee Related JP6061949B2 (ja) | 2011-12-12 | 2012-12-12 | 糖尿病などの疾患の治療のためのｇｌｐ−１受容体モジュレーターとして作用する４つの環を含むカルボン酸誘導体 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8778923B2 (enExample) |
| EP (1) | EP2791112B1 (enExample) |
| JP (1) | JP6061949B2 (enExample) |
| KR (1) | KR20140107340A (enExample) |
| CN (1) | CN104080767A (enExample) |
| AU (1) | AU2012352349B2 (enExample) |
| BR (1) | BR112014013925B1 (enExample) |
| CA (1) | CA2857197C (enExample) |
| ES (1) | ES2836973T3 (enExample) |
| HK (1) | HK1202119A1 (enExample) |
| MX (1) | MX365923B (enExample) |
| RU (1) | RU2634896C2 (enExample) |
| WO (1) | WO2013090454A2 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013530963A (ja) | 2010-06-09 | 2013-08-01 | レセプトス インコーポレイテッド | 新規のｇｌｐ−１受容体安定化薬および調節薬 |
| EP2713722B1 (en) | 2011-05-31 | 2017-03-15 | Receptos, LLC | Novel glp-1 receptor stabilizers and modulators |
| ES2836973T3 (es) | 2011-12-12 | 2021-06-28 | Receptos Llc | Derivados de ácido carboxílico que comprenden cuatro ciclos que actúan como moduladores de receptor GLP-1 para la terapia de enfermedades tales como la diabetes |
| BR112015031040A8 (pt) | 2013-06-11 | 2018-01-02 | Receptos Inc | Novos moduladores do receptor de glp-1 |
| US9474755B2 (en) | 2014-07-25 | 2016-10-25 | Celgene International Ii Sarl | GLP-1 receptor modulators |
| CA2969944A1 (en) | 2014-12-10 | 2016-06-16 | Celgene International Ii Sarl | Glp-1 receptor modulators |
| IL261756B2 (en) | 2016-03-17 | 2023-11-01 | Thiogenesis Therapeutics Inc | Preparations for the controlled release of cysteamine and systemic treatment of disorders sensitive to cysteamine |
| KR102706686B1 (ko) | 2016-05-06 | 2024-09-19 | 아이오니스 파마수티컬즈, 인코포레이티드 | Glp-1 수용체 리간드 모이어티 컨쥬게이트된 올리고뉴클레오티드 및 이의 용도 |
| EA202092442A3 (ru) | 2016-06-07 | 2021-08-31 | Джакобио Фармасьютикалс Ко., Лтд. | Новые гетероциклические производные, применимые в качестве ингибиторов shp2 |
| WO2018172984A1 (en) | 2017-03-23 | 2018-09-27 | Jacobio Pharmaceuticals Co., Ltd. | Novel heterocyclic derivatives useful as shp2 inhibitors |
| CA3060424A1 (en) * | 2017-04-28 | 2018-11-01 | Celgene International Ii Sarl | Novel glp-1 receptor modulators |
| ES3024932T3 (en) | 2017-09-20 | 2025-06-05 | Thiogenesis Therapeutics Inc | Compounds for the treatment of cysteamine sensitive disorders |
| CN112839935A (zh) | 2018-09-26 | 2021-05-25 | 北京加科思新药研发有限公司 | 可用作shp2抑制剂的新型杂环衍生物 |
| CU20210042A7 (es) | 2018-11-22 | 2022-01-13 | Qilu Regor Therapeutics Inc | Compuestos agonistas de glp-1r y composiciones farmacéuticas que lo contienen |
| EP3886854A4 (en) | 2018-11-30 | 2022-07-06 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
| US20220193080A1 (en) * | 2019-04-11 | 2022-06-23 | University Of The Sciences | Allosteric agonists and positive allosteric modulators of glucagon-like peptide 1 receptor |
| BR112021020335A2 (pt) | 2019-04-12 | 2021-12-14 | Qilu Regor Therapeutics Inc | Agonistas glp-1r e usos dos mesmos |
| CN112521501A (zh) * | 2019-09-18 | 2021-03-19 | 鸿运华宁（杭州）生物医药有限公司 | Gipr抗体及其与glp-1的融合蛋白质，以及其药物组合物和应用 |
| PE20221040A1 (es) | 2019-10-25 | 2022-06-17 | Gilead Sciences Inc | Compuestos moduladores de glp-1r |
| MA57692B1 (fr) * | 2019-11-15 | 2025-04-30 | Ildong Pharmaceutical Co., Ltd. | Agoniste du récepteur glp-1 et son utilisation |
| MX2022011349A (es) * | 2020-03-18 | 2022-11-10 | Lg Chemical Ltd | Agonista del receptor de glp-1, composición farmacéutica que comprende el mismo, y método para preparar el mismo. |
| CN113773310B (zh) * | 2020-06-10 | 2023-12-22 | 重庆康丁医药技术有限公司 | 一种具有心血管益处的glp-1小分子 |
| WO2022109182A1 (en) | 2020-11-20 | 2022-05-27 | Gilead Sciences, Inc. | Polyheterocyclic glp-1 r modulating compounds |
| CA3200245A1 (en) | 2020-11-27 | 2022-06-02 | Junjun Wu | Benzimidazole derivative and preparation method therefor and medical use thereof |
| CN117222644A (zh) * | 2021-04-12 | 2023-12-12 | 诺华股份有限公司 | 2-((4-((S)-2-(4-氯-2-氟苯基)-2-甲基苯并[d][1,3]二氧戊环-4-基)哌啶-1-基)甲基)-1-(((S)-氧杂环丁烷-2-基)甲基)-1H-咪唑衍生物作为GLP1受体激活剂治疗肥胖症 |
| PL4271672T3 (pl) | 2021-04-21 | 2026-04-20 | Gilead Sciences, Inc. | Karboksybenzimidazolowe związki modulujące glp-1r |
| AU2024340407A1 (en) | 2023-09-14 | 2026-04-23 | Ascletis Pharma (China) Co., Limited | Glp-1r agonist and therapeutic method thereof |
| WO2025109387A1 (en) | 2023-11-24 | 2025-05-30 | Ascletis Pharma (China) Co., Limited | Glp-1r agonist and therapeutic method thereof |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1062206B (it) | 1974-02-01 | 1983-09-20 | Rotta Research Lab S P A A S | Derivati della tirosina attivi sulla muscolatura liscia |
| DE2423536A1 (de) | 1974-05-15 | 1975-11-27 | Bayer Ag | 3-amino-phenylessigsaeure-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als herbizide |
| US5424286A (en) | 1993-05-24 | 1995-06-13 | Eng; John | Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same |
| US6174905B1 (en) | 1996-09-30 | 2001-01-16 | Mitsui Chemicals, Inc. | Cell differentiation inducer |
| PT1629849E (pt) | 1997-01-07 | 2013-07-09 | Amylin Pharmaceuticals Llc | Composições farmacêuticas que compreendem exendinas e seus agonistas |
| HUP0003921A3 (en) * | 1997-07-31 | 2001-03-28 | Wyeth Corp | Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4, pharmaceutical compositions comprising thereof and their use |
| US6583139B1 (en) * | 1997-07-31 | 2003-06-24 | Eugene D. Thorsett | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| ATE267801T1 (de) * | 1997-08-22 | 2004-06-15 | Hoffmann La Roche | N-alkanoylphenylalaninderivate |
| US6191171B1 (en) | 1997-11-20 | 2001-02-20 | Merck & Co., Inc. | Para-aminomethylaryl carboxamide derivatives |
| PL205713B1 (pl) | 1998-12-07 | 2010-05-31 | Sod Conseils Rech Applic | Związki stanowiące analogi GLP-1, kompozycje farmaceutyczne zawierające takie związki oraz zastosowanie tych związków |
| CN101181236A (zh) | 1999-01-14 | 2008-05-21 | 安米林药品公司 | 新型exendin激动剂制剂及其给药方法 |
| EP1150565A1 (en) * | 1999-02-08 | 2001-11-07 | LION bioscience AG | Thiazole derivatives and combinatorial libraries thereof |
| AU784827B2 (en) | 2000-03-07 | 2006-06-29 | Sanofi-Aventis Deutschland Gmbh | Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase |
| JP4895067B2 (ja) * | 2000-09-29 | 2012-03-14 | 味の素株式会社 | 新規フェニルアラニン誘導体 |
| WO2003048081A2 (en) | 2001-12-04 | 2003-06-12 | Bristol-Myers Squibb Company | Glycinamides as factor xa inhibitors |
| EP1477482B1 (en) * | 2002-02-20 | 2010-04-14 | Ajinomoto Co., Inc. | Novel phenylalanine derivative |
| AU2003235256A1 (en) * | 2002-04-19 | 2003-11-03 | Kyowa Hakko Kogyo Co., Ltd. | Phenylalanine derivative |
| EP1700850B1 (en) | 2003-12-22 | 2015-07-15 | Ajinomoto Co., Inc. | Phenylalanine derivative |
| WO2005077915A1 (en) * | 2004-02-10 | 2005-08-25 | Janssen Pharmaceutica, N.V. | Pyridazinones as antagonists of a4 integrins |
| US7825139B2 (en) | 2005-05-25 | 2010-11-02 | Forest Laboratories Holdings Limited (BM) | Compounds and methods for selective inhibition of dipeptidyl peptidase-IV |
| US8618324B2 (en) | 2007-03-13 | 2013-12-31 | Board Of Regents, The University Of Texas System | Composition and method for making oligo-benzamide compounds |
| CA2688136A1 (en) | 2007-06-08 | 2008-12-11 | Advinus Therapeutics Private Limited | Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application |
| WO2011094890A1 (en) * | 2010-02-02 | 2011-08-11 | Argusina Inc. | Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators |
| JP2013530963A (ja) | 2010-06-09 | 2013-08-01 | レセプトス インコーポレイテッド | 新規のｇｌｐ−１受容体安定化薬および調節薬 |
| EP2713722B1 (en) | 2011-05-31 | 2017-03-15 | Receptos, LLC | Novel glp-1 receptor stabilizers and modulators |
| EP3961933A1 (en) | 2011-06-01 | 2022-03-02 | CommScope Technologies LLC | Interference mitigation in a broadband distributed antenna system with non-duplexer isolator sub-system |
| ES2836973T3 (es) | 2011-12-12 | 2021-06-28 | Receptos Llc | Derivados de ácido carboxílico que comprenden cuatro ciclos que actúan como moduladores de receptor GLP-1 para la terapia de enfermedades tales como la diabetes |
| BR112015031040A8 (pt) | 2013-06-11 | 2018-01-02 | Receptos Inc | Novos moduladores do receptor de glp-1 |
-
2012
- 2012-12-12 ES ES12806828T patent/ES2836973T3/es active Active
- 2012-12-12 BR BR112014013925-3A patent/BR112014013925B1/pt not_active IP Right Cessation
- 2012-12-12 AU AU2012352349A patent/AU2012352349B2/en not_active Ceased
- 2012-12-12 WO PCT/US2012/069289 patent/WO2013090454A2/en not_active Ceased
- 2012-12-12 MX MX2014006622A patent/MX365923B/es active IP Right Grant
- 2012-12-12 KR KR1020147017945A patent/KR20140107340A/ko not_active Withdrawn
- 2012-12-12 CA CA2857197A patent/CA2857197C/en active Active
- 2012-12-12 US US13/712,624 patent/US8778923B2/en active Active
- 2012-12-12 RU RU2014128522A patent/RU2634896C2/ru active
- 2012-12-12 JP JP2014546193A patent/JP6061949B2/ja not_active Expired - Fee Related
- 2012-12-12 HK HK15102640.3A patent/HK1202119A1/xx unknown
- 2012-12-12 CN CN201280060896.1A patent/CN104080767A/zh active Pending
- 2012-12-12 EP EP12806828.5A patent/EP2791112B1/en active Active
-
2014
- 2014-06-05 US US14/296,907 patent/US9187522B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2014128522A (ru) | Новые модуляторы рецептора glp-1 | |
| JP2016528180A5 (enExample) | ||
| JP2014527027A5 (enExample) | ||
| ES2524916T3 (es) | Compuestos heterocíclicos de ácido borónico | |
| TWI385163B (zh) | 吡咯啉啶化合物 | |
| KR101025400B1 (ko) | 치환된 테트라시클린 화합물 | |
| JP2017526734A5 (enExample) | ||
| KR101245062B1 (ko) | 칼슘이온-방출-활성화-칼슘이온 채널을 조절하는 방법 | |
| JP2013510883A5 (enExample) | ||
| RS58475B1 (sr) | Jedinjenja (hetero)aril ciklopropilamina kao lsd1 inhibitori | |
| JP2017524005A5 (enExample) | ||
| JP2015502335A5 (enExample) | ||
| CN1471509A (zh) | 9-取代的二甲胺四环素化合物 | |
| JP2017531019A5 (enExample) | ||
| JP2008513508A (ja) | 炎症及び免疫に関連する用途に用いる化合物 | |
| WO2007049532A1 (ja) | アミノジヒドロチアジン誘導体 | |
| OA12047A (en) | Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents. | |
| RU2016105436A (ru) | Нейроактивные стероиды, композиции и их использование | |
| TW201039814A (en) | Diacylethylenediamine compounds | |
| JP2018524304A5 (enExample) | ||
| JP2017538689A5 (enExample) | ||
| JP2009528273A (ja) | 炎症および免疫関連使用用の置換ビアリール化合物 | |
| JP2017538711A5 (enExample) | ||
| KR20190020170A (ko) | 통풍 또는 고뇨산혈증과 관련된 증상의 치료 또는 예방을 위한 화합물, 조성물 및 방법 | |
| RU2014119711A (ru) | Трициклические соединения, композиции, содержащие указанные соединения, и их применения |